Trevi Therapeutics (TRVI) Research & Development (2018 - 2022)
Trevi Therapeutics' Research & Development came in at $33.48 million for FY2025, down 15.0% from $39.38 million in FY2024.
Powered by 
Analysis
Trevi Therapeutics (TRVI) Research & Development (2018 - 2022) Analysis & Trends
Going back to FY2018, Trevi Therapeutics' Research & Development data covers 8 years.
- Research & Development carries a five-year compound annual growth rate of 8.4% (FY2020 to FY2025).
- The five-year range for annual Research & Development is $19.83 million (FY2022) to $39.38 million (FY2024).
- Per Business Quant, earlier years put Research & Development at $39.38 million in FY2024 (+66.3%), $23.68 million in FY2023 (+19.4%), $19.83 million in FY2022 (-13.7%) and $22.98 million in FY2021 (+2.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.68 Bn | 1,105.26 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 617.43 Bn | 535.95 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 501.53 Bn | 474.64 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 368.15 Bn | 322.53 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 297.54 Bn | 261.53 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 260.75 Bn | 234.43 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 236.53 Bn | 191.93 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 191.10 Bn | 165.30 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 169.66 Bn | 116.31 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Trevi Therapeutics | 2.04 Bn | 1.16 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 4.32 Mn |
| Sep 30, 2022 | 5.77 Mn |
| Jun 30, 2022 | 5.10 Mn |
| Mar 31, 2022 | 4.65 Mn |
| Dec 31, 2021 | 6.18 Mn |
| Sep 30, 2021 | 4.72 Mn |
| Jun 30, 2021 | 6.50 Mn |
| Mar 31, 2021 | 5.59 Mn |
| Dec 31, 2020 | 6.56 Mn |
| Sep 30, 2020 | 4.83 Mn |
| Jun 30, 2020 | 4.92 Mn |
| Mar 31, 2020 | 6.02 Mn |
| Dec 31, 2019 | 4.82 Mn |
| Sep 30, 2019 | 5.65 Mn |
| Jun 30, 2019 | 5.53 Mn |
| Mar 31, 2019 | 3.34 Mn |
| Dec 31, 2018 | 4.52 Mn |
| Sep 30, 2018 | 3.75 Mn |
| Jun 30, 2018 | 3.44 Mn |
| Mar 31, 2018 | 2.36 Mn |
API Access
Trevi Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=TRVI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "TRVI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=TRVI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();